Is Cocrystal Pharma, Inc. (NASDAQ:COCP) Overpaying Its CEO? [Yahoo! Finance News]
Cocrystal Pharma, Inc. (COCP)
NASDAQ:AMEX Investor Relations:
cocrystalpharma.com
Company Research
Source: Yahoo! Finance News
Is Cocrystal Pharma, Inc. (NASDAQ:COCP) Overpaying Its CEO? In 2016 Gary Wilcox was appointed CEO of Cocrystal Pharma, Inc. NASDAQ:COCP See our latest analysis for Cocrystal Pharma How Does Gary Wilcox's Compensation Compare With Similar Sized Companies? According to our data, Cocrystal Pharma, Inc. has a market capitalization of US$42m, and paid its CEO total annual compensation worth US$558k over the year to December 2018. While we always look at total compensation first, we note that the salary component is less, at US$137k. We note that more than half of the total compensation is not the salary; and performance requirements may apply to this non-salary portion. We examined a group of similar sized companies, with market capitalizations of below US$200m. The median CEO total compensation in that group is US$493k. That means Gary Wilcox receives fairly typical remuneration for the CEO of a company that size. This doesn't tell us a whole lot on its own, but looking at the performanc
Show less
Read more
Impact Snapshot
Event Time:
COCP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COCP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COCP alerts
High impacting Cocrystal Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
COCP
News
- Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsGlobeNewswire
- Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season BeginsGlobeNewswire
- Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation [Yahoo! Finance]Yahoo! Finance
COCP
Earnings
- 11/13/24 - Beat
COCP
Sec Filings
- 11/13/24 - Form 8-K
- 11/13/24 - Form 10-Q
- 10/31/24 - Form 8-K
- COCP's page on the SEC website